Susquehanna International Group
IGMS

Susquehanna International Group’s IGM Biosciences IGMS Stock Holding History

Susquehanna International Group’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,700
Closed -$188K – 12921
2024
Q4 		$188K Sell
30,700
-15,800
-34% -$188K ﹤0.01% 10797
2024
Q3 		$769K Buy
46,500
+33,900
+269% +$371K ﹤0.01% 7426
2024
Q2 		$86.6K Buy
+12,600
New +$108K ﹤0.01% 11117
2023
Q3 		– Sell
-16,100
Closed -$149K – 12436
2023
Q2 		$149K Buy
+16,100
New +$180K ﹤0.01% 10590
2022
Q2 		– Sell
-84,700
Closed -$2.26M – 13356
2022
Q1 		$2.26M Buy
84,700
+60,700
+253% +$1.13M ﹤0.01% 5194
2021
Q4 		$704K Buy
24,000
+19,400
+422% +$964K ﹤0.01% 8240
2021
Q3 		$302K Buy
4,600
+1,400
+44% +$107K ﹤0.01% 10588
2021
Q2 		$266K Sell
3,200
-17,100
-84% -$1.27M ﹤0.01% 11032
2021
Q1 		$1.56M Sell
20,300
-10,600
-34% -$965K ﹤0.01% 6536
2020
Q4 		$2.73M Sell
30,900
-124,600
-80% -$8.76M ﹤0.01% 4470
2020
Q3 		$11.5M Buy
+155,500
New +$9.2M ﹤0.01% 2019

Other funds holding IGMS

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's IGMS Position: Q3 2025 in Review

Susquehanna International Group sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 80,311 shares — an estimated $89.9K sold.

Susquehanna International Group first reported a position in IGMS in Q3 2020 and held it in 13 quarters. The position peaked at $2.17M in Q3 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

  • Susquehanna International Group reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 80,311 IGM Biosciences shares in Q3 2025, an estimated $89.9K.
  • Susquehanna International Group first reported a position in IGM Biosciences in Q3 2020 and held it in 13 quarters.
  • Susquehanna International Group's IGM Biosciences position peaked at $2.17M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.